Abstract Development of nanocarriers for drug delivery has received considerable attention
due to their potential in achieving targeted delivery to the diseased site while sparing the …

This review focuses on key topics in the field of drug delivery related to the design of
nanocarriers answering the biomedicine criteria, including biocompatibility, biodegradability …

Abstract Development of nanocarriers has opened new avenues for the delivery of
therapeutics of various pharmacological activities with improved targeting properties and …

Psoriasis is a severe disfiguring skin disease affecting approximately 3% of people
worldwide and negatively affecting their daily lives. The pathogenesis of psoriasis is …

Transdermal drug delivery (TDD) is an alternative method of drug administration for drugs
whose delivery by conventional oral, topical, intravenous and intramuscular methods is of …

Gout is a common inflammatory arthritis caused by persistently elevated uric acid levels.
With the improvement of people's living standards, the consumption of processed food and …

Febuxostat (FXT) is a xanthine oxidase (XO) drug which indicated for the treatment of gout.
FXT loaded nanosized ethosomes were prepared using cold method with varied …

Background Allopurinol (ALP), a xanthine oxidase inhibitor, is a first line drug for the
treatment of gout and hyperuricemia. Being the member of BCS class II drugs, ALP has …

Introduction Inflammation induced by urate deposition in joints causes gout. Healthy
individuals maintain serum levels of urate by balancing urate production/excretion, whereas …

This review highlights in vitro drug dissolution/permeation methods available for topical and
transdermal nanocarriers that have been designed to modulate the propensity of drug …